Prelude Capital Management’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Other funds holding TWST
Prelude Capital Management's TWST Position: Q3 2026 in Review
Prelude Capital Management sold out of Twist Bioscience (TWST) in Q3 2026, closing a stake of 18,976 shares — an estimated $1.95M sold.
Prelude Capital Management first reported a position in TWST in Q2 2020 and held it in 9 quarters. The position peaked at $1.95M in Q2 2026. 435 funds tracked by Wall St. Rank hold TWST as of Q3 2026.
- Prelude Capital Management reported no remaining Twist Bioscience position as of Q3 2026 after selling out during the quarter.
- Prelude Capital Management sold 18,976 Twist Bioscience shares in Q3 2026, an estimated $1.95M.
- Prelude Capital Management first reported a position in Twist Bioscience in Q2 2020 and held it in 9 quarters.
- Prelude Capital Management's Twist Bioscience position peaked at $1.95M in Q2 2026.
- 435 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2026.
Based on Prelude Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.